317 related articles for article (PubMed ID: 17699442)
1. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
2. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
4. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.
Jimenez J; Safranek S; Viera AJ
Am Fam Physician; 2007 Aug; 76(3):423-4. PubMed ID: 17708144
[No Abstract] [Full Text] [Related]
5. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
6. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
7. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
8. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
9. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Katavetin P; Katavetin P
N Engl J Med; 2009 Oct; 361(14):1410-1; author reply 1411. PubMed ID: 19802919
[No Abstract] [Full Text] [Related]
10. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
Fronczyk A; Majkowska L
Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
[TBL] [Abstract][Full Text] [Related]
11. Diabetes complications and the renin-angiotensin system.
Perkins BA; Aiello LP; Krolewski AS
N Engl J Med; 2009 Jul; 361(1):83-5. PubMed ID: 19571288
[No Abstract] [Full Text] [Related]
12. Kidney disease in diabetology: lessons from 2008.
Schernthaner G
Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
[No Abstract] [Full Text] [Related]
13. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Tamsma JT
N Engl J Med; 2009 Oct; 361(14):1410; author reply 1411. PubMed ID: 19797291
[No Abstract] [Full Text] [Related]
14. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic nephropathy and ACE inhibitors].
Amann B
Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i83-7. PubMed ID: 16598556
[TBL] [Abstract][Full Text] [Related]
16. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
Hirsch S
Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
[No Abstract] [Full Text] [Related]
17. Angiotensin-receptor blockade in renal disease: the hard issues.
Sica DA
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):469-71. PubMed ID: 15225107
[No Abstract] [Full Text] [Related]
18. ARBs vs ACE inhibitors for preventing diabetic nephropathy.
Greenwood V
J Fam Pract; 2005 May; 54(5):453; discussion 453-4. PubMed ID: 15865904
[No Abstract] [Full Text] [Related]
19. [Hypertension and diabetic nephropathy, a dangerous duo].
Hausberg M; Hohage H; Kosch M
Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
[No Abstract] [Full Text] [Related]
20. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
